InvestorsHub Logo
Followers 4
Posts 1608
Boards Moderated 0
Alias Born 09/07/2006

Re: None

Tuesday, 05/29/2018 11:46:38 AM

Tuesday, May 29, 2018 11:46:38 AM

Post# of 700929
Finally great news (was about time). I believe one of the most promising findings is this: "For patients with methylated MGMT (n?=?131), mOS was 34.7 months from surgery, with a 3-year survival of 46.4%"

No way price will be this low, must go higher with some coverage and/or some conferences on the horizon.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News